28.01.2010 • NewsArkemaDowMergers & Acquisitions (M&A)

Arkema Integrating Dow Assets

Following Arkema's finalization of its acquisition of Dow assets, the company has announced that the Clear Lakes (Texas) Acrylic Monomers production site is being integrated into the existing Acrylics business unit, within the Industrial Chemicals business segment.

The Acrylic Latex Polymers activity forms a new business unit dedicated to the paint, coatings, adhesives and construction product markets - Arkema Emulsion Systems. This new business unit will be part of the Industrial Chemicals business segment.

Richard Jenkins has been appointed Managing Director of this newly created business unit.

Arkema Emulsion Systems is headquartered in Cary (N.C., U.S.) and operates three latex production facilities in Torrance (Calif.), Alsip (Ill.) and Hahnville (La.). Research and development, marketing, sales and administration functions are located at the Cary, N.C. headquarters.


The Polyphobe Rheology modifiers formerly in the UCAR Emulsion Systems product line are being integrated into Arkema's Coatex subsidiary. By supplying Polyphobe products, Coatex will extend its portfolio for the Paint and Coatings industry to the United States, Canada, Mexico and Puerto Rico markets.

 

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.